{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:14:57Z","timestamp":1792451697851,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Herpes Zoster (HZ) is caused by the reactivation of the varicella zoster virus (VZV). Although aging is the most well-known risk factor for herpes zoster, little is known about the strength of the association between patient-related characteristics, including comorbidities, and their contribution to an increased risk of mortality, among patients hospitalized for HZ. The aim of this study was to assess hospitalization trends and the strength of this association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective population-based study, conducted among all patients hospitalized with HZ in Italy, between January 1st 2011 and December 31st 2023, analysed Hospital Discharge Records (HDR) reporting the ICD-9-CM codes related to HZ infection. Comorbidities that induce a reduced response of VZV-specific cell-mediated immunity - such as malignant neoplasms, chronic obstructive pulmonary disease, kidney diseases, diabetes mellitus, autoimmune diseases - were considered. Poisson regressions models, adjusted for age classes and sex, were used to identify factors associated with an increased risk of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 2011 and 2023, 47,933 hospitalizations with HZ were recorded. HZ comorbidities were diagnosed in 27.71% of cases (13,280 hospitalizations). The analysis revealed that the presence of neoplasms (IRR: 3.15; 95% C.I. 2.61\u20133.78) and kidney disease (IRR: 2.05; 95% C.I. 1.66\u20132.53) increased the risk of death among patients hospitalized with HZ. In the presence of comorbidities, males had a higher risk of death than females, and age was the strongest predictor. The risk increased significantly after the age of 40, reaching an IRR of 37.16 in patients over 80\u2009years old with neoplasms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings of this Real-World study may raise awareness of the risks associated with HZ and support vaccination efforts to prevent infection, particularly among older adults and individuals with comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12319-x","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T15:23:58Z","timestamp":1766676238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comorbidities in hospitalized patients with herpes zoster: an Italian retrospective observational study in the years 2011\u20132023"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6420-8116","authenticated-orcid":false,"given":"Antonella","family":"Mattei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Cialfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"D\u2019Annunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-2342","authenticated-orcid":false,"given":"Fabiana","family":"Fiasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gabutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"12319_CR1","doi-asserted-by":"crossref","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: population based case-control study. BMJ (Online). 2014;348.","DOI":"10.1136\/bmj.g2911"},{"key":"12319_CR2","first-page":"2666","volume-title":"A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect","author":"K Bollaerts","year":"2017","unstructured":"Bollaerts K, Riera-Montes M, Heininger U, Hens N, Souverain A, Verstraeten T, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect. Cambridge University Press; 2017. p. 2666\u201377."},{"key":"12319_CR3","doi-asserted-by":"crossref","unstructured":"Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10.","DOI":"10.1186\/1471-2334-10-230"},{"key":"12319_CR4","doi-asserted-by":"crossref","unstructured":"Salvetti A, Ferrari V, Garofalo R, Gazzaniga P, Guerroni A, Metrucci A, et al. Incidence of herpes zoster and postherpetic neuralgia in Italian adults aged \u226550 years: a prospective study. Prev Med Rep. 2019;14.","DOI":"10.1016\/j.pmedr.2019.100882"},{"key":"12319_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s15010-007-6347-x","volume":"36","author":"AD Heymann","year":"2008","unstructured":"Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green MS, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection. 2008;36:226\u201330.","journal-title":"Infection"},{"key":"12319_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/clinem\/dgab675","volume":"107","author":"CT Huang","year":"2022","unstructured":"Huang CT, Lee CY, Sung HY, Liu SJ, Liang PC, Tsai MC. Association between diabetes mellitus and the risk of herpes zoster: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107:586\u201397.","journal-title":"J Clin Endocrinol Metab"},{"key":"12319_CR7","volume-title":"Herpes zoster: a review of clinical manifestations and management. Viruses","author":"A Patil","year":"2022","unstructured":"Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses. MDPI; 2022."},{"key":"12319_CR8","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1017\/S0950268814003653","volume":"143","author":"B Liu","year":"2015","unstructured":"Liu B, Heywood AE, Reekie J, Banks E, Kaldor JM, Mcintyre P, et al. Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study. Epidemiol Infect. 2015;143:2871\u201381.","journal-title":"Epidemiol Infect"},{"key":"12319_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s13555-021-00535-7","volume":"11","author":"M Batram","year":"2021","unstructured":"Batram M, Witte J, Schwarz M, Hain J, Ultsch B, Steinmann M, et al. Burden of herpes zoster in adult patients with underlying conditions: analysis of German claims data, 2007-2018. Dermatol Ther (Heidelb). 2021;11:1009\u201326.","journal-title":"Dermatol Ther (heidelb)"},{"key":"12319_CR10","doi-asserted-by":"crossref","unstructured":"Scampoli P, Di Martino G, Cedrone F, Odio C, Di Giovanni P, Romano F, et al. The burden of herpes zoster on hospital admissions: a retrospective analysis in the years of 2015\u20132021 from the Abruzzo Region, Italy. Vaccines (Basel). 2024;12.","DOI":"10.3390\/vaccines12050462"},{"key":"12319_CR11","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/bjc.2017.124","volume":"116","author":"E Hansson","year":"2017","unstructured":"Hansson E, Forbes HJ, Langan SM, Smeeth L, Bhaskaran K. Herpes zoster risk after 21 specific cancers: population-based case-control study. Br J Cancer. 2017;116:1643\u201351.","journal-title":"Br J Cancer"},{"key":"12319_CR12","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang S-J, et al. Efficacy of an adjuvanted herpes zoster Subunit vaccine in older adults. N Engl J Med. 2015;372:2087\u201396.","journal-title":"N Engl J Med"},{"key":"12319_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/cid\/ciab125","volume":"73","author":"HS Izurieta","year":"2021","unstructured":"Izurieta HS, Wu X, Forshee R, Lu Y, Sung HM, Agger PE, et al. Recombinant zoster vaccine (Shingrix): real-world effectiveness in the first 2 years post-licensure. Clin Infect Dis. 2021;73:941\u201348.","journal-title":"Clin Infect Dis"},{"key":"12319_CR14","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","volume":"92","author":"K Kawai","year":"2017","unstructured":"Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc. 2017;92:1806\u201321.","journal-title":"Mayo Clin Proc"},{"key":"12319_CR15","unstructured":"European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zostavax. Accessed 4 September 2025."},{"key":"12319_CR16","unstructured":"Ministry of Health. National vaccination Prevention Plan (PNPV) 2023-2025. Ministry of health of Italy. 2023."},{"key":"12319_CR17","doi-asserted-by":"crossref","unstructured":"Salussolia A, Capodici A, Scognamiglio F, La Fauci G, Sold\u00e0 G, Montalti M, et al. Herpes zoster (HZ) vaccine coverage and confidence in Italy: a nationwide cross-sectional study, the obvious project. BMC Infect Dis. 2024;24.","DOI":"10.1186\/s12879-024-09344-7"},{"key":"12319_CR18","doi-asserted-by":"crossref","unstructured":"Gabutti G, Serenelli C, Cavallaro A, Ragni P. Herpes zoster associated hospital admissions in Italy: review of the hospital discharge forms. Int J Environ Res Public Health. MDPI. 2009;2344\u201353.","DOI":"10.3390\/ijerph6092344"},{"key":"12319_CR19","doi-asserted-by":"crossref","unstructured":"Buchan SA, Daneman N, Wang J, Wilson SE, Garber G, Wormsbecker AE, et al. Herpes zoster in older adults in Ontario, 2002-2016. Investigating incidence and exploring equity. PLoS One. 2021;16.","DOI":"10.1371\/journal.pone.0246086"},{"key":"12319_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s40520-021-02014-7","volume":"34","author":"E Amodio","year":"2022","unstructured":"Amodio E, Marrella A, Casuccio A, Vitale F. Decline in hospitalization rates for herpes zoster in Italy (2003-2018): reduction in the burden of disease or changing of hospitalization criteria? Aging Clin Exp Res. 2022;34:881\u201386.","journal-title":"Aging Clin Exp Res"},{"key":"12319_CR21","unstructured":"ISTAT - Istituto Nazionale di Statistica. Popolazione residente per et\u00e0, sesso e stato civile (2011-2023). https:\/\/www.istat.it\/. Accessed 4 September 2025."},{"key":"12319_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40520-017-0782-z","volume":"29","author":"N Valente","year":"2017","unstructured":"Valente N, Cocchio S, Stefanati A, Baldovin T, Martinelli D, Prato R, et al. Temporal trends in herpes zoster-related hospitalizations in Italy, 2001-2013. differences between regions that have or have not implemented varicella vaccination. Aging Clin Exp Res. 2017;29:771\u201379.","journal-title":"Aging Clin Exp Res"},{"key":"12319_CR23","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1016\/j.vaccine.2007.07.049","volume":"25","author":"V Di Legami","year":"2007","unstructured":"Di Legami V, Gianino MM, Atti MCD, Massari M, Migliardi A, Tomba GS, et al. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine. 2007;25:7598\u2013604.","journal-title":"Vaccine"},{"key":"12319_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciw296","volume":"63","author":"K Kawai","year":"2021","unstructured":"Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2021;63:221\u201326.","journal-title":"Clin Infect Dis"},{"key":"12319_CR25","doi-asserted-by":"crossref","unstructured":"Cedrone F, Di Martino G, Di Giovanni P, Greco E, Trebbi E, Romano F, et al. Reduction in hospital admissions for cardiovascular diseases (CVDs) during the coronavirus disease 2019 (COVID-19) pandemic: a retrospective study from a Southern Italian Region in the Year 2020. Healthcare (Switz). 2022;10.","DOI":"10.3390\/healthcare10050871"},{"key":"12319_CR26","doi-asserted-by":"crossref","unstructured":"Cedrone F, Montagna V, Del Duca L, Camplone L, Mazzocca R, Carfagnini F, et al. The burden of streptococcus pneumoniae-related admissions and In-hospital mortality: a retrospective observational study between the Years 2015 and 2022 from a Southern Italian province. Vaccines (Basel). 2023;11.","DOI":"10.3390\/vaccines11081324"},{"key":"12319_CR27","unstructured":"Italian Ministry of Health. Available at https:\/\/www.salute.gov.it\/new\/it\/pubblicazione\/rapporto-annuale-sullattivita-di-ricovero-ospedaliero-dati-sdo-2023\/?utm. Accessed on 3 November 2025."},{"key":"12319_CR28","doi-asserted-by":"crossref","unstructured":"Redondo-Sendino \u00c1, Guallar-Castill\u00f3n P, Banegas JR, Rodr\u00edguez-Artalejo F. Gender differences in the utilization of health-care services among the older adult population of Spain. BMC Public Health. 2006;6.","DOI":"10.1186\/1471-2458-6-155"},{"key":"12319_CR29","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1016\/S0264-410X(03)00459-6","volume":"21","author":"GS Goldman","year":"2003","unstructured":"Goldman GS. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine. 2003;21:4243\u201349.","journal-title":"Vaccine"},{"key":"12319_CR30","doi-asserted-by":"crossref","unstructured":"Ogunjimi B, Van Den Bergh J, Meysman P, Heynderickx S, Bergs K, Jansen H, et al. Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Sci Rep. 2017;7.","DOI":"10.1038\/s41598-017-01024-8"},{"key":"12319_CR31","doi-asserted-by":"crossref","unstructured":"Forbes H, Douglas I, Finn A, Breuer J, Bhaskaran K, Smeeth L, et al. Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data. BMJ. 2020;368.","DOI":"10.1136\/bmj.l6987"},{"key":"12319_CR32","doi-asserted-by":"crossref","unstructured":"Levin MJ. Immune senescence and vaccines to prevent herpes zoster in older persons. Curr Opin Immunol. 2012;494\u2013500.","DOI":"10.1016\/j.coi.2012.06.002"},{"key":"12319_CR33","doi-asserted-by":"crossref","unstructured":"Liu YC, Yang YH, Hsiao HH, Yang WC, Liu TC, Chang CS, et al. Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan. BMC Cancer. 2012;12.","DOI":"10.1186\/1471-2407-12-503"},{"key":"12319_CR34","doi-asserted-by":"crossref","unstructured":"Saadatian-Elahi M, Bauduceau B, Del-Signore C, Vanhems P. Diabetes as a risk factor for herpes zoster in adults: a synthetic literature review. Diabetes Res Clin Pract. Elsevier Ireland Ltd; 2020.","DOI":"10.1016\/j.diabres.2019.107983"},{"key":"12319_CR35","first-page":"E25292","volume":"100","author":"SW Lai","year":"2021","unstructured":"Lai SW, Liu CS, Kuo YH, Lin CL, Hwang BF, Liao KF. The incidence of herpes zoster in patients with diabetes mellitus: a meta-analysis of cohort studies. Medicine (U States). 2021;100:E25292.","journal-title":"Med (U States)"},{"issue":"11","key":"12319_CR36","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","volume":"88","author":"AD Deshpande","year":"2008","unstructured":"Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. Nov 2008;88(11):1254\u201364. https:\/\/doi.org\/10.2522\/ptj.20080020. Epub 2008 Sep 18. PMID: 18801858; PMCID: PMC3870323.","journal-title":"Phys Ther"},{"issue":"9","key":"12319_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","volume":"18","author":"D Tomic","year":"2022","unstructured":"Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. Sep 2022;18(9):525\u201339. https:\/\/doi.org\/10.1038\/s41574-022-00690-7. Epub 2022 Jun 6. PMID: 35668219; PMCID: PMC9169030.","journal-title":"Nat Rev Endocrinol"},{"key":"12319_CR38","first-page":"1","volume":"85","author":"F Fiasca","year":"2019","unstructured":"Fiasca F, Necozione S, Fabiani L, Mastrodomenico M, Mattei A. Measles-related hospitalizations in italy, 2004-2016. The importance of high vaccination coverage. Ann Glob Health. 2019;85:1\u20139.","journal-title":"Ann Glob Health"},{"key":"12319_CR39","unstructured":"de Campora E, Pizzuti R, Lodato S, Cau N. Hospital discharge records (SDO) as a source of information for epidemiological studies. Italian National Institute of Health. 2006. https:\/\/www.epicentro.iss.it\/ben\/2002\/febbraio02\/3_en. Accessed 4 September 2025."},{"key":"12319_CR40","unstructured":"Lispi L, Gallo M, Colandrea C, Campolongo A, Ceccolini C, Rossi A, et al. Rapporto annuale sull\u2019attivit\u00e0 di ricovero ospedaliero - Dati SDO 2023, gennaio 2025. https:\/\/www.salute.gov.it\/new\/it\/pubblicazione\/rapporto-annuale-sullattivita-di-ricovero-ospedaliero-dati-sdo-2023\/. Accessed 4 September 2025."},{"key":"12319_CR41","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00592-023-02127-7","volume":"60","author":"GA Silverii","year":"2023","unstructured":"Silverii GA, Clerico A, Fornengo R, Gabutti G, Sordi V, Peruzzi O, et al. Efficacy and effectiveness of herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies. Acta Diabetol. 2023;60:1343\u201349.","journal-title":"Acta Diabetol"},{"key":"12319_CR42","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s15010-023-02156-y","volume":"52","author":"M Steinmann","year":"2024","unstructured":"Steinmann M, Lampe D, Grosser J, Schmidt J, Hohoff ML, Fischer A, et al. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns. Infection. 2024;52:1009\u201326.","journal-title":"Infection"},{"key":"12319_CR43","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.ekir.2021.02.024","volume":"6","author":"MA Hamad","year":"2021","unstructured":"Hamad MA, Allam H, Sulaiman A, Murali K, Cheikh Hassan HI. Systematic review and meta-analysis of herpes zoster vaccine in patients with CKD. Kidney Int Rep. 2021;6:1254\u201364.","journal-title":"Kidney Int Rep"},{"key":"12319_CR44","unstructured":"Italian Association of Medical Oncology (AIOM). Guidelines: vaccination of the oncology patient. 2025. Rome: AIOM. https:\/\/www.simg.it\/wp-content\/uploads\/2025\/02\/LG_C0032_AIOM_Vaccinazione.pdf. Accessed 4 September 2025."},{"key":"12319_CR45","unstructured":"Italian Society of Rheumatology (SIR). Recommendations of the Italian Society of Rheumatology on vaccina-tions in patients with rheumatic diseases. Milan: SIR. 2022. https:\/\/www.reumatologia.it\/obj\/files\/lineeguida\/1-Vaccinazioni_malattie_reumatologiche-raccomandazioni.pdf. Accessed 4 September 2025."},{"issue":"8","key":"12319_CR46","first-page":"556","volume":"104","author":"C Micheletto","year":"2025","unstructured":"Micheletto C, Aliberti S, Andreoni M, Blasi F, Di Marco F, Di Matteo R, et al. Vaccination strategies in respiratory diseases: recommendation from AIPO-ITS\/ETS. SIMIT SIP\/IRS SItI Respiration. 2025;104(8):556\u201374.","journal-title":"SIMIT SIP\/IRS SItI Respiration"},{"key":"12319_CR47","doi-asserted-by":"crossref","unstructured":"Pedrazzoli P, Lasagna A, Cassaniti I, Ferrari A, Bergami F, Silvestris N, et al. Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM). ESMO Open. Elsevier B.V. 2022.","DOI":"10.1016\/j.esmoop.2022.100548"},{"key":"12319_CR48","doi-asserted-by":"publisher","first-page":"101345","DOI":"10.1016\/j.eclinm.2022.101345","volume":"46","author":"C Allegri","year":"2022","unstructured":"Allegri C, Banks H, Devillanova C. Avoidable hospitalizations and access to primary care: comparisons among Italians, resident immigrants and undocumented immigrants in administrative hospital discharge records. EClinicalMedicine. 2022;46:101345. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101345.","journal-title":"EClinicalMedicine"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12319-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12319-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12319-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:57:07Z","timestamp":1769518627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12319-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12319"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12319-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data provided by the Ministry of Health did not contain any patient identifiers and were therefore completely anonymous. Our retrospective observational study, as other studies based on hospital discharge database, fulfills the Italian regulations of ethics committees, which require only standard written informed consent at the time of hospital admission [\n                      \n                      ]. This epidemiologic investigation was carried out in accordance with the ethical principles for human research outlined in the Declaration of Helsinki. The request for evaluation of this observational study has been approved by the Internal Review Board (University of L\u2019Aquila, protocol number 20338, dated 16 February 2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}